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Background
Individuals with acquired immunodeficiency are at heigh-
tened risk for multiple subtypes of cancer. Among sarco-
mas, increased risk in both adults and children has been
identified only for Kaposi’s sarcoma (KS), and in HIV-
infected children for leiomyosarcoma. In contrast, broader
diversity in subtypes of lymphomas and carcinomas has
been reported. Sarcomas constitute <1% of all incident
cancers in the general population. Modest increases in risk
of rare sarcoma categories in the immunocompromised
may thus be difficult to capture. We therefore reviewed
published data from case reports/series to describe sar-
coma subtypes in HIV-infected individuals and solid organ
transplant recipients.
Methods
Literature review of sarcoma case reports in people with
HIV and recipients of organ transplants were conducted
using PubMed and citation searches. Surveillance Epide-
miology and End Results (SEER) data (1974-2008) were
queried to obtain counts of each type of sarcoma, and the
age distribution of leiomyosarcomas.
Results
A total of 152 cases of sarcomas (other than KS) were
identified in people with HIV/AIDS (n=62) and in recipi-
ents of solid organ transplants (n=90). Leiomyosarcomas
represented the bulk of all sarcomas (98/152), followed by
angiosarcoma (16/152) and fibrohistiocytic tumors (15/
152). Compared to the distribution of sarcomas in SEER,
leiomyosarcoma was overrepresented by 4-fold (16.9% in
SEER; 64.4% in immunodeficiency). Ages of HIV-related
leiomyosarcoma cases suggested a bimodal distribution
with an early peak among 0-9 year olds (36%) and later
among 30-39 year olds (34%). More than 80% of immuno-
deficiency-related leiomyosarcomas were Epstein-Barr
virus (EBV)-positive. Most HIV-related leiomyosarcomas
(>93%) were in people with AIDS diagnoses and the
majority of transplant-related leiomyosarcomas (>62%)
were reported in renal transplant recipients. Leiomyomas
were also reported in people with immunodeficiency
(n=37), and >65% of leiomyomas and leiomyosarcomas
reported in people with HIV infection occurred with CD4
counts of <50 cells/mm
3. All 14 cases of transplant-related
angiosaromas were in renal transplants. Ninety three per-
cent (13) occurred in males. Ha l fo ft r a n s p l a n t - r e l a t e d
angiosarcomas occurred at the site of an arteriovenous
fistula.
Conclusions
EBV-positive smooth muscle tumors are frequently
reported in people with immunosupression. Both children
and adults are at risk for leiomyosarcomas. Leiomyomas
and leiomyosarcomas occurred with the same propensity
in people with CD4 counts below 50. Angiosarcomas
occurred specifically in males in renal transplant recipients
and may be related to an arteriovenous fistula.
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